- Home
- VRDN vs NRP Comparison
VRDN vs NRP Comparison
Compare VRDN & NRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- NRP
- Stock Information
- Founded
- VRDN 2006
- NRP 2002
- Country
- VRDN United States
- NRP United States
- Employees
- VRDN N/A
- NRP N/A
- Industry
- VRDN Medical Specialities
- NRP Coal Mining
- Sector
- VRDN Health Care
- NRP Energy
- Exchange
- VRDN Nasdaq
- NRP Nasdaq
- Market Cap
- VRDN 1.6B
- NRP 1.4B
- IPO Year
- VRDN N/A
- NRP N/A
- Fundamental
- Price
- VRDN $19.64
- NRP $105.03
- Analyst Decision
- VRDN Strong Buy
- NRP
- Analyst Count
- VRDN 11
- NRP 0
- Target Price
- VRDN $37.63
- NRP N/A
- AVG Volume (30 Days)
- VRDN 1.4M
- NRP 31.6K
- Earning Date
- VRDN 11-12-2024
- NRP 11-05-2024
- Dividend Yield
- VRDN N/A
- NRP 2.88%
- EPS Growth
- VRDN N/A
- NRP 4.50
- EPS
- VRDN N/A
- NRP 12.60
- Revenue
- VRDN $302,000.00
- NRP $256,666,000.00
- Revenue This Year
- VRDN $2.55
- NRP N/A
- Revenue Next Year
- VRDN N/A
- NRP N/A
- P/E Ratio
- VRDN N/A
- NRP $8.26
- Revenue Growth
- VRDN N/A
- NRP N/A
- 52 Week Low
- VRDN $11.40
- NRP $81.74
- 52 Week High
- VRDN $27.20
- NRP $113.04
- Technical
- Relative Strength Index (RSI)
- VRDN 49.14
- NRP 43.77
- Support Level
- VRDN $20.06
- NRP $105.05
- Resistance Level
- VRDN $23.65
- NRP $109.32
- Average True Range (ATR)
- VRDN 1.05
- NRP 3.24
- MACD
- VRDN 0.16
- NRP -0.84
- Stochastic Oscillator
- VRDN 49.45
- NRP 18.19
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About NRP Natural Resource Partners LP Limited Partnership
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.